Pancreatic Cyst Found on a Scan: What Does It Mean and What Happens Next?

A pancreatic cyst found on a scan is a fluid-filled pocket in or on the pancreas, usually discovered by chance on CT or MRI done for another reason. Most pancreatic cysts never cause harm. Cleveland Clinic states that fewer than 1% turn into cancer, but because some types can change, many are monitored with repeat imaging.

Finding the word 'cyst' near the word 'pancreas' can be frightening. This guide explains the common cyst types, the warning features that published guidelines describe and the questions to bring to your clinician. It cannot tell you which type you have or what your own risk is.

Most incidental cysts cause no symptoms, and a cyst on a report is not an emergency by itself. Some symptoms, however, should not wait for a routine follow-up scan.

The NHS advises calling emergency services or going to an emergency department for sudden, severe tummy pain that spreads to the back, a fast heartbeat or difficulty breathing. These can be signs of acute pancreatitis. Yellowing of the skin or the whites of the eyes (jaundice), often with dark urine, pale stools or itching, needs urgent medical advice; the NHS suggests an urgent GP appointment or NHS 111 in the UK, or your local equivalent.

• Sudden, severe upper tummy pain, especially if it spreads to the back or comes with vomiting or fever.
• Yellow skin or eyes, dark urine or pale, greasy stools.
• Unexplained weight loss or new diabetes. Tell your team rather than waiting for the next scan.

Very common, and risk rises with age. Cleveland Clinic notes that about 10% of CT scans and MRIs show pancreatic cysts, usually by chance. The 2018 European evidence-based guidelines report a wide range of estimates, higher on MRI than on CT, because MRI picks up very small cysts.

Doctors group pancreatic cysts by what lines them and whether they can change. A report may not name the type at first; sometimes the type is only a 'presumed' or 'likely' diagnosis based on how the cyst looks.

• Serous cystadenoma (serous cystic neoplasm): generally benign. The European guideline describes it as a benign entity and suggests symptom-based follow-up after the first year once the diagnosis is clear.
• Intraductal papillary mucinous neoplasm (IPMN): the most common cyst type that can become cancer. Branch-duct IPMNs are usually benign; IPMNs involving the main pancreatic duct carry more concern.
• Mucinous cystic neoplasm (MCN): a mucin-producing cyst that mainly affects women and is considered precancerous.
• Pseudocyst: not a true growth but a pocket of fluid that forms when pancreatic juices leak. It is benign.
• Solid pseudopapillary neoplasm: rare, with solid and fluid parts, and considered precancerous.

Guidelines use specific features to decide who needs more tests, such as endoscopic ultrasound, or referral to a specialist pancreas team. The American College of Gastroenterology (ACG) 2018 guideline lists the following as reasons for further evaluation:

• Jaundice or acute pancreatitis caused by the cyst.
• A significantly raised CA 19-9 blood marker.
• A mural nodule or solid component in the cyst or nearby pancreas.
• A main pancreatic duct wider than 5 mm, or a focal change in duct calibre.
• A mucin-producing cyst of 3 cm or more.
• High-grade dysplasia or cancer on cytology (cells taken from the cyst).

MRI with MRCP, a type of MRI that shows the pancreatic and bile ducts, is the preferred surveillance test in both the ACG and European guidelines. It does not use radiation and shows the ducts well. Endoscopic ultrasound, in which a thin scope images the pancreas from inside the stomach and can take a fluid sample, is used when the diagnosis is unclear or worrying features appear.

If a fluid sample is taken during endoscopic ultrasound, Cleveland Clinic explains that the laboratory can look for mucin and tumour markers such as CEA, and examine the cells. These results help separate mucinous cysts from benign types. Surgery is considered for cysts that look suspicious, cause complications or meet guideline thresholds, and it carries its own risks, including diabetes and digestive problems, which is why most cysts are watched rather than removed.

How often you are scanned depends on the cyst type, size and any changes. The European guideline suggests 6-monthly follow-up in the first year for IPMN without surgical indications, then yearly. ACG suggests that intervals can be lengthened once a cyst is stable. Growth during surveillance can prompt a shorter interval or further tests.

Guidelines also say that surveillance makes sense only while a person would be fit for surgery if a change were found. A clinician may advise against further testing for someone who could not have surgery. That is a shared decision, not a sign of being dismissed.

Bring the full written report, not just a summary. These questions can help you understand your own result and plan:

• What type of cyst do you think this is, and how sure is that?
• How big is it, and is the main pancreatic duct normal in width?
• Does the report mention any worrying features, such as a solid nodule?
• Do I need MRI/MRCP, endoscopic ultrasound or blood tests, and when?
• How often will I be scanned, and for how long?
• Who will contact me with results, and what should I do if I develop symptoms in between?

On SameCase, patients and verified doctors share de-identified cases. Reading how others with a similar report approached their follow-up can help you see which questions people found useful, such as how scan intervals were chosen or what endoscopic ultrasound involved.

Other people's cases cannot tell you what your cyst is or what will happen to it. Use them to prepare questions, and let your own care team interpret your scans.

Scans of the abdomen often mention more than one incidental finding. If your report also describes a kidney cyst or a gallbladder polyp, our separate guides explain those findings and their own follow-up rules, which differ from those for the pancreas.